Source: Virtual Congress 2020 – Clinical and basic pharmacology for COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. Andreasson (Gothenburg, Sweden), L. Odqvist (Gothenburg, Sweden), S. Arlbrandt (Gothenburg, Sweden), C. Wingren (Gothenburg, Sweden), P. Berntsson (Gothenburg, Sweden), M. Rhedin (Gothenburg, Sweden), M. Dearman (Cambridge, United Kingdom), A. Borde (Gothenburg, Sweden), M. Birrell (Gothenburg, Sweden), A. Åstrand (Gothenburg, Sweden). Inhaled bacterial mimetic increases PAD4-dependent NETosis in the lungs. 182

Member's Comments

No comment yet.

Related content which might interest you: Oral N-acetylcysteine attenuates the rat pulmonary inflammatory response to antigen Source: Eur Respir J 2003; 21: 394-400 Year: 2003 Inhaled cationic salts modulate macrophage function to reduce inflammation during LPS induced lung injury Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD Year: 2012 Neurokinins and nitric oxide modulate airway remodeling in a model of lung allergic inflammation Source: Eur Respir J 2005; 26: Suppl. 49, 578s Year: 2005 Lactose-β-sitosterol inhibits ovalbumin-induced asthmatic inflammation with no influence on nitric oxide pathway Source: Annual Congress 2010 - Animal models of asthma and lung inflammation Year: 2010 Inhaled insulin does not trigger lung inflammation and airway remodelling Source: Eur Respir J 2009; 33: 444-445 Year: 2009 Inhaled nitric oxide increases alveolar liquid clearance in rabbit with endotoxin induced lung injury Source: Eur Respir J 2004; 24: Suppl. 48, 101s Year: 2004 Different inhaled corticosteroids altered lung microbiome and regulating the expression of PAF receptor as well as the phagocytosis function of macrophage Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations Year: 2019 AZD7624, an inhaled p38 inhibitor for COPD, attenuates lung and systemic inflammation after LPS Challenge in humans Source: International Congress 2015 – Advances in the future treatment of COPD Year: 2015 Resveratrol impairs the release of steroid-resistant cytokines from bacterial endotoxin-exposed alveolar macrophages (AM) in COPD Source: Annual Congress 2011 - Experimental modulation of airway inflammation Year: 2011 iNOS-derived nitric oxide modulates inflammatory cell apoptosis in a model of chronic allergic pulmonary inflammation in guinea pigs Source: Eur Respir J 2006; 28: Suppl. 50, 760s Year: 2006 Chronic nitric oxide inhibition modulates inflammatory cells apoptosis induced by dexamethasone in guinea pigs with chronic airway inflammation Source: Eur Respir J 2005; 26: Suppl. 49, 368s Year: 2005 Chronic nitric oxide inhibition increases airway remodeling in guinea pigs with lung inflammation Source: Annual Congress 2004 - Animal models of asthma and chronic bronchitis and their relevance in pulmonary pharmacology Year: 2004 iNOS depletion completely diminishes reactive nitrogen-species formation after an allergic response Source: Eur Respir J 2002; 20: 609-616 Year: 2002 Translocation of TNF-α from the gut to the lung by VILI is reduced by exogenous surfactant therapy Source: Eur Respir J 2002; 20: Suppl. 38, 375s Year: 2002 Role of FAS-induced apoptosis and nitric oxide overproduction in ventilator-associated pneumonia Source: Eur Respir J 2005; 26: Suppl. 49, 189s Year: 2005 Regulated lung-specific overexpression of nitric oxide induces airway hyperresponsiveness in mice Source: Eur Respir J 2002; 20: Suppl. 38, 568s Year: 2002 Inhaled CCR1 antagonist AZD4818 reduces leucocyte influx in the rat lipopolysaccharide (LPS) lung inflammation model Source: Annual Congress 2009 - Preclinical models in drug development Year: 2009 Interaction between nitric oxide, dexamethasone and montelukast controlling airway chronic inflammatory cell recruitment in guinea pigs Source: Eur Respir J 2004; 24: Suppl. 48, 350s Year: 2004 Inducible nitric oxide synthase inhibition modulates lung tissue extracellular matrix remodelling induced by chronic allergic inflammation Source: Annual Congress 2007 - New treatments for asthma and COPD - experimental evidence Year: 2007 Role of lipid mediators and nitric oxide (NO) in the immediate lung response to lipopolysaccharide Source: Eur Respir J 2002; 20: Suppl. 38, 228s Year: 2002